Robinson Cole LLP
High Contrast Mode
Marquee

Appellate

Robinson+Cole recognizes the importance of putting appeals in the hands of lawyers who are specially trained in the art of appellate advocacy. Our Appellate litigation practice group is fluent in appellate rules, and our lawyers are highly skilled in issue identification, issue preservation, strategic positioning, and persuasive argument. We understand how to best craft and present legal issues to jurists, having spent decades developing our talents.

In addition to our long and strong presence in the Connecticut appellate courts, our team has developed a national insurance appellate practice and also regularly handles appeals in Florida, New York, New Jersey, and throughout New England. Our appellate work has also brought us to numerous state courts including Arizona, California, Delaware, Florida, Louisiana, Mississippi, Nevada, and Texas, to name a few. Naturally, we also have extensive experience in the federal circuit courts of appeal, having appeared in 12 of the 13 circuits.

Our Services

We represent a wide range of clients, including insurers and sureties, financial institutions, employers, manufacturers, construction companies, and private individuals. Anyone who might find themselves in litigation may eventually have need of our services (to reverse an unfavorable outcome in a lower court or to defend an advantageous one). We manage all aspects of the case and, working in close collaboration with trial counsel, guide the matter throughout all stages of the appellate process. This process often includes:

  • An initial assessment of the matter and recommendation re strength of appellate position;
  • Brainstorming of possible issues on appeal, including all applicable standards of review;
  • Strategic identification of the most promising issues to focus on strongest claims with optimal outcomes;
  • Coordination and participation in any pre-appeal settlement program;
  • Ensuring an adequate appellate record;
  • Writing and editing persuasive opening, responsive, and reply briefs;
  • Careful preparation for oral argument, including a mock or practice argument;
  • Appearance in court for oral argument; and
  • Assessment of appropriate next steps following release of the appellate court’s final judgment.

Our Appellate lawyers also frequently represent amici curiae, such as industry associations, in filing amicus (friend-of-the-court) briefs to, for example, suggest an additional route to decision, provide a historical or technical perspective, or address policy issues.

In addition to the traditional appellate level matter, our Appellate lawyers are also often asked to attend and monitor trials in the lower courts, especially in high-stakes litigation where an appeal is anticipated by the losing party.  Less often, we are asked to get deeply involved in matters in lower courts where it is determined that the case will likely resolve by virtue of strong legal briefing (say, on an early motion to dismiss or a mid-case motion for summary judgment). By becoming involved in cases months or years before judgment enters, we can provide indispensable know-how in pretrial motion practice and also in following the matter as it progresses (especially when it comes to strategic planning and issue preservation).

Finally, we also bring our appellate vision, persuasive briefing skills, and strong oral advocacy to many different kinds of closed-record proceedings, such as state and federal administrative agency appeals, arbitration appeals, ERISA appeals, and bankruptcy appeals.  

Our Team

For more than 40 years, our firm’s roster has included leading appellate advocates. Our Appellate litigation team lawyers have been involved in successful appeals in the U.S. Supreme Court and the highest courts in Connecticut, New York, New Jersey, New England, South Carolina, and Virginia. Most of our lawyers are former appellate law clerks, who are particularly well-suited to handle appeals in any forum.

We provide seamlessly integrated legal services by collaborating with colleagues throughout our firm’s diverse practice groups, including Business Litigation, Insurance + Reinsurance, Business Transactions, Environmental, Energy + Telecommunications; Health Law; Labor, Employment, Benefits + Immigration, and Land Use.

Our Appellate litigation lawyers are adept team players who will strive to achieve the very best results to support your goals.

Experience


Represented MD Labs in First Circuit Victory for Clinical Lab in False Claims Act Appeal

Successfully represented MD Labs and its owners in defending against False Claims Act allegations in U.S. ex rel. Omni Healthcare Inc. v. MD Spine Solutions LLC et al., securing summary judgment in the District of Massachusetts and a unanimous affirmation by the U.S. Court of Appeals for the First Circuit. This landmark decision clarified that clinical laboratories may rely on doctor’s orders to show that the test is “reasonable and necessary” and confirmed that commissions to independent contractors are not per se illegal — setting an important precedent for clinical laboratories nationwide.

Read More
Represented MD Labs in First Circuit Victory for Clinical Lab in False Claims Act Appeal

Supreme Court Declines Review of ERISA Applicability to duPont Family Employee Trust

The U.S. Court of Appeals for the Third Circuit reversed the Delaware District Court’s 2019 decision determining that ERISA applied to a trust established for the benefit of certain domestic and personal service employees of duPont family members.

The plaintiff employee of one of the duPont family members whose employees are potential beneficiaries under the trust, argued that the trust serves as an employment benefit plan covered by the Employee Retirement and Income Security Act of 1974 (ERISA) and that compliance with ERISA was required. The trust had operated as a state law trust since its establishment in 1947 and, as time went on and as anticipated, the corpus of the trust continued to decline.

The Third Circuit ruled that the employee failed to present a connection between her employer and other family members recognized as employers, a requirement for an ERISA-protected multiple employer plan. She also failed to prove that her employer ever financially supported or maintained the trust—a key component for ERISA applicability.

The employee subsequently petitioned the U.S. Supreme Court to review whether ERISA applied to the trust—including minimum funding requirements. The Supreme Court declined to consider the case, leaving the Third Circuit’s decision in place.

One of America’s most well-known families, the duPont family has roots in gunpowder manufacturing and the now-chemical company still bears its name.

The Robinson+Cole team included Business Litigation Group member Curtis Crowther and Appellate Group chair Linda Morkan.

Read More
Supreme Court Declines Review of ERISA Applicability to duPont Family Employee Trust

Appellate: COVID-19 Business Interruption Claim – Eighth Circuit

Briefed and argued appeal in the U.S. Court of Appeals for the Eighth Circuit involving claim by a municipality under a policy providing coverage for loss of sales tax revenue in specified circumstances. The court agreed with our client’s position and affirmed the trial court’s declaratory judgment that the policy provisions were not ambiguous or in conflict, and that there was no coverage without direct physical loss or damage to property at the relevant locations.

Read More


Publications


December 4, 2025

11th Circ.’s 6-Step Review May Be Ripe for Insurer Challenge

Law360 Expert Analysis

By a 2-1 vote in Johnson v. Reliance Standard Life Insurance Co., the U.S. Court of Appeals for the Eleventh Circuit has held that a policy interpretation endorsed by the dissenting opinion, suggested by a prior Eleventh Circuit panel, and adopted by other courts around the country was not just wrong, but so unreasonable that it failed arbitrary-and-capricious review. The Nov. 21 decision is a cautionary tale in several respects.[1] The dispute arose under a long-term disability, or LTD, policy that excluded coverage for preexisting conditions, defined as "any Sickness or Injury for which the Insured received medical Treatment, consultation, care or services, including diagnostic procedures, or took prescribed drugs or medicines." For two years prepolicy, the plaintiff had symptoms of a rare autoimmune disease, scleroderma. She received treatment, took medicines, and underwent diagnostic procedures. But none of her doctors could figure out what it was, diagnosing her with nearly a dozen other ailments instead. After the policy kicked in, her doctors landed on the correct diagnosis. The question for the court was whether something counts as a preexisting condition if the insured was treated for it prepolicy, but her doctors didn't name it correctly. The Result The majority answered no, holding that the insurer thus wrongly denied coverage. This outcome was unlikely for two main reasons. First, this was an LTD policy under the Employee Retirement Income Security Act that granted the insurer "discretionary authority" to interpret it. The insurer could lose only if its interpretation was not just wrong, but so unreasonable as to be "arbitrary and capricious." Second, multiple judges already had interpreted similar policy language in line with the insurer's interpretation. The deferential standard of review may have been diluted in part due to a quirk of the Eleventh Circuit. In contrast to other circuits that apply regular abuse-of-discretion review to an insurer's discretionary interpretation of its own ERISA policy, the Eleventh Circuit uses a bespoke six-step sequence that starts by asking whether the insurer's interpretation is wrong under de novo review, then only later asks if it is so wrong as to be arbitrary and capricious. This sequence triggers what influence scholar and renowned psychologist Robert Cialdini calls "commitment-and-consistency bias": Someone is more likely to agree with a stance if they first agree with it a little. Here, once a judge convinces themself that an interpretation is wrong, there is a stronger cognitive temptation to believe it is also very wrong. By contrast, leading with the abuse-of-discretion question creates a more level playing field. Second, at the policy interpretation stage, things got metaphysical. The majority viewed the Scott Garosshen prepolicy doctors' activities as treating symptoms rather than a medical condition. Because they repeatedly misdiagnosed the plaintiff with other ailments instead of scleroderma, the majority reasoned, they could not have been treating her "for" scleroderma. The "symptoms are not the disease" and "an indication of something is not the thing itself," just as "a wet umbrella is [not] 'the same thing' as a hurricane." The dissent saw it differently. The plaintiff had been treated, prescribed medication, and undergone diagnostics "for the 'various symptoms and conditions of scleroderma.'" There was "more than mere 'consistency' between what [she] was treated for and scleroderma; they are the same thing." Borrowing an umbrella of its own, the dissent reasoned that if one "us[es] an umbrella to stay dry without knowing whether the current rainstorm is a hurricane or quick summer shower," either way, "the umbrella fends off the rains." Since both majority and dissent found different dictionaries and prior cases siding with their respective interpretations, one would expect the insurer to prevail under arbitrary-andcapricious review. Instead, the majority seized on a stray answer at oral argument, construing it as an admission that the insurer would deny coverage if any prepolicy symptom was not inconsistent with the later diagnosis. The majority held that that position, albeit taken from another party in a different case, "is unreasonable — full stop." So, it reversed the judgment of the U.S. District Court for the Northern District of Georgia. Looking Ahead This appeal seems ripe for rehearing en banc; although, this is quite rare, especially in insurance coverage cases. As to standard of review, even the majority acknowledged that the Eleventh Circuit's six-step sequence "is likely unnecessarily complex (and may even obscure the lawful result in certain cases)" — the result here is a prime example. If not now, then when the right case comes along, insurers may consider investing in overturning this framework and the subtle cognitive bias it creates. Doing so will aid not just litigants, but also the court. That six-step structure does not only obscure the correct result; it is also unwieldy to apply. The majority nodded to this when it suggested in passing that the contra proferentem rule, requiring a court to defer to the policyholder's reasonable interpretation of ambiguous language, might bolster its conclusion at interpretive step one — i.e., whether, under de novo review, the insurer's interpretation was wrong. Critically, that rule goes out the window at step three — during abuse-of-discretion review, a court must defer to the insurer's reasonable interpretation of ambiguous language. So, the court winds up disregarding its earlier work. Other circuits hold overwhelmingly that contra proferentem simply plays no role in abuseof-discretion review.[2] Only the U.S. Court of Appeals for the Fifth Circuit, in its 2019 decision in Dialysis Newco Inc. v. Community Health Systems Group Health Plan, has come out differently in the limited context of interpreting anti-assignment clauses, while acknowledging that this outlier holding created "some tension in [its] caselaw" and may be due for correction.[3] It is thus no wonder that the Eleventh Circuit majority here, after invoking contra proferentem, disavowed any reliance on it, even in step one. That awkward dance (and the makework it entails) could be avoided if the Eleventh Circuit jettisons the six-step framework and joins the rest of the country in assessing simply whether the insurer has discretion, and, if so, whether its interpretation passes abuse-of-discretion review. Turning to the Eleventh Circuit majority's merits policy interpretation, how lower courts apply that test will be key. The test seems to be that the right disease need not be formally diagnosed prepolicy so long as it at least is "suspected." The majority suggests that "strong indications" of the particular illness, "reasonable cause" to diagnose the particular illness, or "a distinct symptom or condition from which one learned in medicine can diagnose the disease" all trigger the preexisting conditions exclusion but were not satisfied on the facts here. Whether that blurry line will yield consistent results in practice remains to be seen. Key Takeaways for Insurers 1. Look out for interpretive frameworks that create commitment-and-consistency bias. Experiments have shown that judges are susceptible to this type of cognitive effect. Although hard to prove in any given case, the long-term effect can be significant. Investing in reshaping the law into a more level playing field affects not just the individual cases but also their broader ripples into adjacent case law. 2. Pay special attention to outlier circuits. When a circuit decision flags one of its own rules as out-of-step with the modern trend, it may be vulnerable to reconsideration en banc, without the need for a trip all the way to One First Street, Washington, D.C. This is especially true when experience has shown the rule to be unworkable. 3. Issue framing and careful answers at oral argument matter. Insurers are often held to a higher standard, even when the law requires more lenient treatment. The effect of this can be mitigated by having a firm theory of the case and knowing exactly when one can, cannot, or must cede ground. [1] Johnson v. Reliance Standard Life Insurance Company, No. 23-13443, 2025 WL 3251015 (11th Cir. Nov. 21, 2025). [2] Dialysis Newco Inc. v. Cmty. Health Sys. Grp. Health Plan, 938 F.3d 246, 251 n.4 (5th Cir. 2019) (noting decisions from the First, Second, Fourth, Sixth, Seventh, Ninth, Tenth and Eleventh Circuits). [3] Dialysis Newco, 938 F.3d at 251.

Spring 2021

Video Calls and Video Hearings Primer

ABA Tort Trial & Insurance Practice Section (TIPS) Appellate Advocacy Committee Newsletter

View the article. .

June 20, 2011

Vacating Arbitration Decision Not an Appealing Task

Connecticut Law Tribune

View the article.

December 4, 2025

11th Circ.’s 6-Step Review May Be Ripe for Insurer Challenge

Law360 Expert Analysis

By a 2-1 vote in Johnson v. Reliance Standard Life Insurance Co., the U.S. Court of Appeals for the Eleventh Circuit has held that a policy interpretation endorsed by the dissenting opinion, suggested by a prior Eleventh Circuit panel, and adopted by other courts around the country was not just wrong, but so unreasonable that it failed arbitrary-and-capricious review. The Nov. 21 decision is a cautionary tale in several respects.[1] The dispute arose under a long-term disability, or LTD, policy that excluded coverage for preexisting conditions, defined as "any Sickness or Injury for which the Insured received medical Treatment, consultation, care or services, including diagnostic procedures, or took prescribed drugs or medicines." For two years prepolicy, the plaintiff had symptoms of a rare autoimmune disease, scleroderma. She received treatment, took medicines, and underwent diagnostic procedures. But none of her doctors could figure out what it was, diagnosing her with nearly a dozen other ailments instead. After the policy kicked in, her doctors landed on the correct diagnosis. The question for the court was whether something counts as a preexisting condition if the insured was treated for it prepolicy, but her doctors didn't name it correctly. The Result The majority answered no, holding that the insurer thus wrongly denied coverage. This outcome was unlikely for two main reasons. First, this was an LTD policy under the Employee Retirement Income Security Act that granted the insurer "discretionary authority" to interpret it. The insurer could lose only if its interpretation was not just wrong, but so unreasonable as to be "arbitrary and capricious." Second, multiple judges already had interpreted similar policy language in line with the insurer's interpretation. The deferential standard of review may have been diluted in part due to a quirk of the Eleventh Circuit. In contrast to other circuits that apply regular abuse-of-discretion review to an insurer's discretionary interpretation of its own ERISA policy, the Eleventh Circuit uses a bespoke six-step sequence that starts by asking whether the insurer's interpretation is wrong under de novo review, then only later asks if it is so wrong as to be arbitrary and capricious. This sequence triggers what influence scholar and renowned psychologist Robert Cialdini calls "commitment-and-consistency bias": Someone is more likely to agree with a stance if they first agree with it a little. Here, once a judge convinces themself that an interpretation is wrong, there is a stronger cognitive temptation to believe it is also very wrong. By contrast, leading with the abuse-of-discretion question creates a more level playing field. Second, at the policy interpretation stage, things got metaphysical. The majority viewed the Scott Garosshen prepolicy doctors' activities as treating symptoms rather than a medical condition. Because they repeatedly misdiagnosed the plaintiff with other ailments instead of scleroderma, the majority reasoned, they could not have been treating her "for" scleroderma. The "symptoms are not the disease" and "an indication of something is not the thing itself," just as "a wet umbrella is [not] 'the same thing' as a hurricane." The dissent saw it differently. The plaintiff had been treated, prescribed medication, and undergone diagnostics "for the 'various symptoms and conditions of scleroderma.'" There was "more than mere 'consistency' between what [she] was treated for and scleroderma; they are the same thing." Borrowing an umbrella of its own, the dissent reasoned that if one "us[es] an umbrella to stay dry without knowing whether the current rainstorm is a hurricane or quick summer shower," either way, "the umbrella fends off the rains." Since both majority and dissent found different dictionaries and prior cases siding with their respective interpretations, one would expect the insurer to prevail under arbitrary-andcapricious review. Instead, the majority seized on a stray answer at oral argument, construing it as an admission that the insurer would deny coverage if any prepolicy symptom was not inconsistent with the later diagnosis. The majority held that that position, albeit taken from another party in a different case, "is unreasonable — full stop." So, it reversed the judgment of the U.S. District Court for the Northern District of Georgia. Looking Ahead This appeal seems ripe for rehearing en banc; although, this is quite rare, especially in insurance coverage cases. As to standard of review, even the majority acknowledged that the Eleventh Circuit's six-step sequence "is likely unnecessarily complex (and may even obscure the lawful result in certain cases)" — the result here is a prime example. If not now, then when the right case comes along, insurers may consider investing in overturning this framework and the subtle cognitive bias it creates. Doing so will aid not just litigants, but also the court. That six-step structure does not only obscure the correct result; it is also unwieldy to apply. The majority nodded to this when it suggested in passing that the contra proferentem rule, requiring a court to defer to the policyholder's reasonable interpretation of ambiguous language, might bolster its conclusion at interpretive step one — i.e., whether, under de novo review, the insurer's interpretation was wrong. Critically, that rule goes out the window at step three — during abuse-of-discretion review, a court must defer to the insurer's reasonable interpretation of ambiguous language. So, the court winds up disregarding its earlier work. Other circuits hold overwhelmingly that contra proferentem simply plays no role in abuseof-discretion review.[2] Only the U.S. Court of Appeals for the Fifth Circuit, in its 2019 decision in Dialysis Newco Inc. v. Community Health Systems Group Health Plan, has come out differently in the limited context of interpreting anti-assignment clauses, while acknowledging that this outlier holding created "some tension in [its] caselaw" and may be due for correction.[3] It is thus no wonder that the Eleventh Circuit majority here, after invoking contra proferentem, disavowed any reliance on it, even in step one. That awkward dance (and the makework it entails) could be avoided if the Eleventh Circuit jettisons the six-step framework and joins the rest of the country in assessing simply whether the insurer has discretion, and, if so, whether its interpretation passes abuse-of-discretion review. Turning to the Eleventh Circuit majority's merits policy interpretation, how lower courts apply that test will be key. The test seems to be that the right disease need not be formally diagnosed prepolicy so long as it at least is "suspected." The majority suggests that "strong indications" of the particular illness, "reasonable cause" to diagnose the particular illness, or "a distinct symptom or condition from which one learned in medicine can diagnose the disease" all trigger the preexisting conditions exclusion but were not satisfied on the facts here. Whether that blurry line will yield consistent results in practice remains to be seen. Key Takeaways for Insurers 1. Look out for interpretive frameworks that create commitment-and-consistency bias. Experiments have shown that judges are susceptible to this type of cognitive effect. Although hard to prove in any given case, the long-term effect can be significant. Investing in reshaping the law into a more level playing field affects not just the individual cases but also their broader ripples into adjacent case law. 2. Pay special attention to outlier circuits. When a circuit decision flags one of its own rules as out-of-step with the modern trend, it may be vulnerable to reconsideration en banc, without the need for a trip all the way to One First Street, Washington, D.C. This is especially true when experience has shown the rule to be unworkable. 3. Issue framing and careful answers at oral argument matter. Insurers are often held to a higher standard, even when the law requires more lenient treatment. The effect of this can be mitigated by having a firm theory of the case and knowing exactly when one can, cannot, or must cede ground. [1] Johnson v. Reliance Standard Life Insurance Company, No. 23-13443, 2025 WL 3251015 (11th Cir. Nov. 21, 2025). [2] Dialysis Newco Inc. v. Cmty. Health Sys. Grp. Health Plan, 938 F.3d 246, 251 n.4 (5th Cir. 2019) (noting decisions from the First, Second, Fourth, Sixth, Seventh, Ninth, Tenth and Eleventh Circuits). [3] Dialysis Newco, 938 F.3d at 251.

Spring 2021

Video Calls and Video Hearings Primer

ABA Tort Trial & Insurance Practice Section (TIPS) Appellate Advocacy Committee Newsletter

View the article. .

June 20, 2011

Vacating Arbitration Decision Not an Appealing Task

Connecticut Law Tribune

View the article.

July 2007

Visual Rhetoric in the Appellate Brief

DRI For The Defense
2007

Superseding and Staying Judgements: A National Compendium

2006

Clarity Is an Absolute for Effective Advocacy

DRI For The Defense
2005

Take the Time to Think!

DRI For The Defense 
January 2004

Beware of Euphemisms

DRI For The Defense
June 3, 2002

First, Let's Sue All the Lawyers

Connecticut Law Tribune


July 2007

Visual Rhetoric in the Appellate Brief

DRI For The Defense
2007

Superseding and Staying Judgements: A National Compendium

2006

Clarity Is an Absolute for Effective Advocacy

DRI For The Defense
2005

Take the Time to Think!

DRI For The Defense 
January 2004

Beware of Euphemisms

DRI For The Defense
June 3, 2002

First, Let's Sue All the Lawyers

Connecticut Law Tribune

News


December 11, 2025

Scott Garosshen Authors Article on Policy Interpretation for Preexisting Conditions

Appellate group lawyer Scott Garosshen recently authored an article titled “11th Circ.’s 6-Step Review May Be Ripe for Insurer Challenge” published in Law360 Expert Analysis on December 4, 2025. In an expansion of their post for the firm’s Covering Appeals blog, Scott discusses a recent decision by the U.S. Court of Appeals for the Eleventh Circuit concerning long-term disability coverage based on preexisting condition exclusions; how “commitment-and-consistency bias” can impact a judge’s interpretation of policy coverage; and how a future appeal could overturn the Eleventh Circuit’s unique six-step framework for reviewing coverage. “The question for the court was whether something counts as a preexisting condition if the insured was treated for it prepolicy, but [their] doctors didn’t name it correctly,” writes Scott. “The majority answered no, holding that the insurer thus wrongly denied coverage. This was unlikely for two main reasons[:] [f]irst, this was a [long-term disability] policy under the Employee Retirement Income Security Act that granted the insurer ‘discretionary authority,’ [to interpret coverage]; [s]econd, multiple judges already had interpreted similar policy language in line with the insurer’s interpretation.” Scott continues, here “[t]he deferential standard of review may have been diluted in part due to a quirk of the Eleventh Circuit,” highlighting that, unlike other circuits, the Eleventh Circuit uses a “bespoke six-step sequence” that asks, “whether the insurer’s interpretation is wrong under de novo review” and only later questions “if it is so wrong [as] to be arbitrary and capricious.” Read the article.

Law360 Expert Analysis
December 4, 2025

Health Care Enforcement Team Secures First Circuit Win for Clinical Lab in False Claims Act Appeal

November 14, 2025

Robinson+Cole Secures Top Rankings in 2026 Edition of Best Law Firms®

Firm earns 6 national and 46 first-tier rankings in Boston, Hartford, New York, Rhode Island, and Stamford Markets
Robinson+Cole Secures Top Rankings in 2026 Edition of Best Law Firms® teaser
December 11, 2025

Scott Garosshen Authors Article on Policy Interpretation for Preexisting Conditions

Appellate group lawyer Scott Garosshen recently authored an article titled “11th Circ.’s 6-Step Review May Be Ripe for Insurer Challenge” published in Law360 Expert Analysis on December 4, 2025. In an expansion of their post for the firm’s Covering Appeals blog, Scott discusses a recent decision by the U.S. Court of Appeals for the Eleventh Circuit concerning long-term disability coverage based on preexisting condition exclusions; how “commitment-and-consistency bias” can impact a judge’s interpretation of policy coverage; and how a future appeal could overturn the Eleventh Circuit’s unique six-step framework for reviewing coverage. “The question for the court was whether something counts as a preexisting condition if the insured was treated for it prepolicy, but [their] doctors didn’t name it correctly,” writes Scott. “The majority answered no, holding that the insurer thus wrongly denied coverage. This was unlikely for two main reasons[:] [f]irst, this was a [long-term disability] policy under the Employee Retirement Income Security Act that granted the insurer ‘discretionary authority,’ [to interpret coverage]; [s]econd, multiple judges already had interpreted similar policy language in line with the insurer’s interpretation.” Scott continues, here “[t]he deferential standard of review may have been diluted in part due to a quirk of the Eleventh Circuit,” highlighting that, unlike other circuits, the Eleventh Circuit uses a “bespoke six-step sequence” that asks, “whether the insurer’s interpretation is wrong under de novo review” and only later questions “if it is so wrong [as] to be arbitrary and capricious.” Read the article.

Law360 Expert Analysis
December 4, 2025

Health Care Enforcement Team Secures First Circuit Win for Clinical Lab in False Claims Act Appeal

November 14, 2025

Robinson+Cole Secures Top Rankings in 2026 Edition of Best Law Firms®

Firm earns 6 national and 46 first-tier rankings in Boston, Hartford, New York, Rhode Island, and Stamford Markets
Robinson+Cole Secures Top Rankings in 2026 Edition of Best Law Firms® teaser
November 6, 2025

Robinson+Cole Commends 62 Attorneys Recognized in 2025 Super Lawyers®

Recognition spans key regions and highlights the firm’s seasoned practitioners and emerging leaders in many business transactions and litigation practices
Robinson+Cole Commends 62 Attorneys Recognized in 2025 <i>Super Lawyers</i>® teaser
August 26, 2025

78 Robinson+Cole Lawyers Listed in The Best Lawyers in America© 2026

Firm receives top listing in Connecticut lawyer count in national peer review survey
78 Robinson+Cole Lawyers Listed in The Best Lawyers in America© 2026 teaser
June 3, 2025

Scott Garosshen Elected to the CT Supreme Court Historical Society’s Board of Directors

May 12, 2025

Scott Garosshen Named to CCADV’s First 100 Plus Class of 2025

Connecticut Coalition Against Domestic Violence
November 7, 2024

Robinson+Cole Receives 45 First-Tier Metropolitan Rankings and Six National Rankings in 2025 Edition of Best Law Firms®

Robinson+Cole Receives 45 First-Tier Metropolitan Rankings and Six National Rankings in 2025 Edition of <i>Best Law Firms</i>® teaser
October 31, 2024

Robinson+Cole Lawyers Recognized in 2024 Super Lawyers®

Thomson Reuters
Robinson+Cole Lawyers Recognized in 2024 <i>Super Lawyers</i>® teaser

November 6, 2025

Robinson+Cole Commends 62 Attorneys Recognized in 2025 Super Lawyers®

Recognition spans key regions and highlights the firm’s seasoned practitioners and emerging leaders in many business transactions and litigation practices
Robinson+Cole Commends 62 Attorneys Recognized in 2025 <i>Super Lawyers</i>® teaser
August 26, 2025

78 Robinson+Cole Lawyers Listed in The Best Lawyers in America© 2026

Firm receives top listing in Connecticut lawyer count in national peer review survey
78 Robinson+Cole Lawyers Listed in The Best Lawyers in America© 2026 teaser
June 3, 2025

Scott Garosshen Elected to the CT Supreme Court Historical Society’s Board of Directors

May 12, 2025

Scott Garosshen Named to CCADV’s First 100 Plus Class of 2025

Connecticut Coalition Against Domestic Violence
November 7, 2024

Robinson+Cole Receives 45 First-Tier Metropolitan Rankings and Six National Rankings in 2025 Edition of Best Law Firms®

Robinson+Cole Receives 45 First-Tier Metropolitan Rankings and Six National Rankings in 2025 Edition of <i>Best Law Firms</i>® teaser
October 31, 2024

Robinson+Cole Lawyers Recognized in 2024 Super Lawyers®

Thomson Reuters
Robinson+Cole Lawyers Recognized in 2024 <i>Super Lawyers</i>® teaser

Events


Past

Appellate 101

Mar 11 2026
Presented by the Appellate Advocacy Section - Part of the Solo/Small Firm CLE Series
Past

Appealing Outcomes: Strategies for Success in Bankruptcy Appeals

Oct 9 2025
CBA 2025 Connecticut Bankruptcy Conference
Past

Appellate 101

Mar 11 2026
Presented by the Appellate Advocacy Section - Part of the Solo/Small Firm CLE Series
Past

Appealing Outcomes: Strategies for Success in Bankruptcy Appeals

Oct 9 2025
CBA 2025 Connecticut Bankruptcy Conference
Past

Taking a Step Back: Overall Case Strategy

May 15 2025
Connecticut Bar Association Litigation Section 2025 Litigation Retreat
Past

Lecture on Strategy and Persuasion

Nov 21 2024
Connecticut Bar Association (CBA) Appellate Advocacy Section’s 2024 Appellate Advocacy Institute
Past

Appellate Advocacy Institute

November 21-22, 2024
Appellate Advocacy Section of the Connecticut Bar Association
Past

A Discussion with the Honorable Dawne G. Westbrook

Oct 2 2024
Appellate Advocacy Section Meeting of the Connecticut Bar Association
Past

Taking a Step Back: Overall Case Strategy

May 15 2025
Connecticut Bar Association Litigation Section 2025 Litigation Retreat
Past

Lecture on Strategy and Persuasion

Nov 21 2024
Connecticut Bar Association (CBA) Appellate Advocacy Section’s 2024 Appellate Advocacy Institute
Past

Appellate Advocacy Institute

November 21-22, 2024
Appellate Advocacy Section of the Connecticut Bar Association
Past

A Discussion with the Honorable Dawne G. Westbrook

Oct 2 2024
Appellate Advocacy Section Meeting of the Connecticut Bar Association